Should we Consider the Next ICD Trial in the Acute Coronary Syndrome Patients with Monomorphic VT?doi:10.1016/j.hrthm.2018.03.003ZarebaWojciechHeart Rhythm
In our cohort, the combined prevalence of cardiogenic shock and cardiorenal syndrome exceeds one-third, marking a substantial portion of patients at an increased risk of these acute complications. This high prevalence lends further support to the potential immediate impacts of GLP-1 RAs37, possibly ...
Implantable Cardioverter Defibrillator (ICD) Use in New Zealand: A 3 Year Analysis from the All New Zealand Acute Coronary Syndrome- Quality Improvement Device Registry (ANZACS-QI DEVICE)Implantable Cardioverter Defibrillator (ICD) Use in New Zealand: A 3 Year Analysis from the All New Zealand Acu...
Heart failure is the prevalent complication of acute myocardial infarction. We aim to identify a biomarker for heart failure post-acute myocardial infarction. This observational study includes 1062 and 1043 patients with acute myocardial infarction in th
FIELD: medicine.;SUBSTANCE: in patients after acute coronary syndrome, in 3-6 wk after stabilization of their clinical state it is necessary to prescribe a training cycle consisted of 2 stages, each being of 3-mo-long period. During this training course one should control patient's heart ...
Background: Contemporary guidelines advocate for early invasive strategy with coronary angiography in patients with non-ST-elevation acute coronary syndromes (NSTE-ACS). Still, the impact of an invasive strategy in older patients remains controversial an